Clinical Trials

NCT IdNCT04107428
TitleSomatostatin in Living Donor Liver Transplantation
ConditionEnd Stage Liver DIsease
StudyTypeInterventional
OrganizationKing Faisal Specialist Hospital & Research Center
Sponsor/CollaboratorsKing Faisal Specialist Hospital & Research Center
StatusNot yet recruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
DescriptionAim of the study is to investigate the safety and the efficacy of somatostatin as liver inflow modulator in patients with end-stage liver disease (ESLD) and clinically significant portal hypertension (CSPH) undergoing Adult-to-Adult living donor liver transplantation (A2ALDLT).